Mirum Pharmaceuticals
MIRM
67 hedge funds and large institutions have $405M invested in Mirum Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 21 increasing their positions, 23 reducing their positions, and 3 closing their positions.
233% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 3
10% more funds holding
Funds holding: 61 → 67 (+6)
0.02% more ownership
Funds ownership: 76.83% → 76.86% (+0.02%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
9% less repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 23
13% less capital invested
Capital invested by funds: $463M → $405M (-$58.6M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$4.27M |
| 2 |
Axa
Paris,
France
|
+$1.66M |
| 3 |
Renaissance Technologies
New York
|
+$885K |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$885K |
| 5 |
Morgan Stanley
New York
|
+$798K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SI
Sofinnova Investments
Menlo Park,
California
|
-$3.89M |
| 2 |
BlackRock
New York
|
-$2.74M |
| 3 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$2.56M |
| 4 |
Millennium Management
New York
|
-$679K |
| 5 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
-$358K |
MIRM Hedge Fund Activity: Q2 2021 in Review
67 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Mirum Pharmaceuticals (MIRM) for Q2 2021, worth a combined $405M — down 13% from $463M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new MIRM positions and 3 closed out — a net gain of 7 holders — while 21 added to existing stakes and 23 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $4.27M. The largest seller was Sofinnova Investments, cutting an estimated $3.89M.
- 67 institutional investors held Mirum Pharmaceuticals (MIRM) as of Q2 2021, up from 61 in Q1 2021.
- Funds reported $405M of Mirum Pharmaceuticals stock for Q2 2021, down 13% quarter-over-quarter.
- 10 funds opened new Mirum Pharmaceuticals positions in Q2 2021 and 3 closed out, a net change of +7 holders.
- The largest Mirum Pharmaceuticals buyer in Q2 2021 was Wellington Management Group, an estimated $4.27M added.
- The largest Mirum Pharmaceuticals seller in Q2 2021 was Sofinnova Investments, an estimated $3.89M sold.
Based on aggregated 13F filings for Q2 2021.